Rosiglitazone and cardiovascular risk

N Engl J Med. 2007 Aug 30;357(9):938-9; author reply 939-40.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Bayes Theorem
  • Cardiovascular Diseases / chemically induced
  • Cardiovascular Diseases / mortality*
  • Data Interpretation, Statistical
  • Diabetes Mellitus, Type 2 / drug therapy
  • Humans
  • Hypoglycemic Agents / adverse effects*
  • Meta-Analysis as Topic
  • Myocardial Infarction / chemically induced*
  • Odds Ratio
  • Risk
  • Rosiglitazone
  • Thiazolidinediones / adverse effects*

Substances

  • Hypoglycemic Agents
  • Thiazolidinediones
  • Rosiglitazone